ALNAのニュース
RETA, ALNA and BSGM among mid-day movers 2022/09/07 17:28:34 Seeking Alpha
Gainers: IMARA IMRA +61%.Allena Pharmaceuticals (ALNA) +49%.Azure Power Global (AZRE) +32%.SelectQuote SLQT +26%.Shuttle Pharmaceuticals SHPH +25%.Glaukos GKOS +25%.Sidus…
Why Korn Ferry Is Trading Lower By Over 8%, Here Are 40 Stocks Moving In Wednesday''s Mid-Day Session 2022/09/07 16:22:21 Benzinga
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA ) jumped 64% … Full story available on Benzinga.com
Thinking about buying stock in Allena Pharmaceuticals, Spero Therapeutics, Signify Health, Avaya Holdings, or Frontline? 2022/09/06 18:32:00 Benzinga
NEW YORK , Sept. 6, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ALNA, SPRO, SGFY, AVYA, and FRO. … Full story available on Benzinga.com
Allena Pharmaceuticals Shares Fall After Filing For Bankruptcy 2022/09/06 11:06:56 Benzinga
Full story available on Benzinga.com
Allena Pharmaceuticals Inc. (ALNA) Rises From The Low: Could It Be A Catbird Seat? 2022/09/02 14:30:00 Stocks Register
Allena Pharmaceuticals Inc. (NASDAQ:ALNA) concluded the trading at $0.10 on Thursday, September 01 with a fall of -2.47% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $0.11 and 5Y monthly beta was reading 1.42 with its price kept floating in the … Allena Pharmaceuticals Inc. (ALNA) Rises From The Low: Could It Be A Catbird Seat? Read More »
RETA, ALNA and BSGM among mid-day movers 2022/09/07 17:28:34 Seeking Alpha
Gainers: IMARA IMRA +61%.Allena Pharmaceuticals (ALNA) +49%.Azure Power Global (AZRE) +32%.SelectQuote SLQT +26%.Shuttle Pharmaceuticals SHPH +25%.Glaukos GKOS +25%.Sidus…
Why Korn Ferry Is Trading Lower By Over 8%, Here Are 40 Stocks Moving In Wednesday''s Mid-Day Session 2022/09/07 16:22:21 Benzinga
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA ) jumped 64% … Full story available on Benzinga.com
Thinking about buying stock in Allena Pharmaceuticals, Spero Therapeutics, Signify Health, Avaya Holdings, or Frontline? 2022/09/06 18:32:00 Benzinga
NEW YORK , Sept. 6, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ALNA, SPRO, SGFY, AVYA, and FRO. … Full story available on Benzinga.com
Allena Pharmaceuticals Shares Fall After Filing For Bankruptcy 2022/09/06 11:06:56 Benzinga
Full story available on Benzinga.com
Allena Pharmaceuticals Inc. (ALNA) Rises From The Low: Could It Be A Catbird Seat? 2022/09/02 14:30:00 Stocks Register
Allena Pharmaceuticals Inc. (NASDAQ:ALNA) concluded the trading at $0.10 on Thursday, September 01 with a fall of -2.47% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $0.11 and 5Y monthly beta was reading 1.42 with its price kept floating in the … Allena Pharmaceuticals Inc. (ALNA) Rises From The Low: Could It Be A Catbird Seat? Read More »
Bright Trending Stock: Allena Pharmaceuticals, Inc. (NASDAQ:ALNA), Rio Tinto Group (NYSE:RIO) 2022/02/23 03:17:40 Stock Equity
Allena Pharmaceuticals, Inc. (NASDAQ:ALNA) with the stream of -5.30% also noticed, India Rio Tinto Group (NYSE:RIO) encountered a rapid change of 0.18% in the last hour of Tuesdays trading session. The post Bright Trending Stock: Allena Pharmaceuticals, Inc. (NASDAQ:ALNA), Rio Tinto Group (NYSE:RIO) appeared first on Stocks Equity .
Allena Pharmaceuticals Inc Shares Approach 52-Week Low - Market Mover 2022/01/14 05:09:59 Kwhen Finance
Allena Pharmaceuticals Inc (ALNA) shares closed today at 0.4% above its 52 week low of $0.46, giving the company a market cap of $39M. The stock is currently down 19.2% year-to-date, down 65.5% over the past 12 months, and down 95.2% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 rose 0.6%. Trading Activity Trading volume this week was 58.5% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.6. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 533.5% The company's stock price performance over the past 12 months lags the peer average by 114.8%
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
Allena Pharmaceuticals: A Double [Or More] Or Kaput In The Next 90 Days 2022/01/08 05:36:25 Seeking Alpha
Traders should divert their intention on this Stock: Allena Pharmaceuticals, Inc. (NASDAQ:ALNA), Galiano Gold Inc. (AMEX:GAU) 2021/12/24 04:46:20 Stock Equity
Allena Pharmaceuticals, Inc. (NASDAQ:ALNA) with the stream of -0.41% also noticed, India Galiano Gold Inc. (AMEX:GAU) encountered a rapid change of 0.63% in the last hour of Thursdays trading session. The post Traders should divert their intention on this Stock: Allena Pharmaceuticals, Inc. (NASDAQ:ALNA), Galiano Gold Inc. (AMEX:GAU) appeared first on Stocks Equity .
Allena Pharmaceuticals (NASDAQ:ALNA) Upgraded by Zacks Investment Research to Buy 2021/12/22 07:46:42 Dakota Financial News
Zacks Investment Research upgraded shares of Allena Pharmaceuticals (NASDAQ:ALNA) from a hold rating to a buy rating in a research report sent to investors on Tuesday, Zacks.com reports. The brokerage currently has $0.75 price target on the stock. According to Zacks, Allena Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in developing and commercializing oral []